AGRX - Agile Therapeutics Inc
Previous close
1.51
0 0%
Share volume: 56,184
Last Updated: Mon 26 Aug 2024 06:00:00 AM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$1.51
0.00
0.00%
Summary score
5%
Profitability
0%
Dept financing
5%
Liquidity
50%
Performance
0%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-16.94%
Return on assets
-12.7%
Return on sales
0%
Return on invested capital
-94.79%
Total debt ratio
22.19%
Debt ratio change over timeo
-1.15%
Current Ratio
7.36%
Quick Ratio
0%
Cash Position Ratio
6.96%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-12.29%
Return on assets
-10.59%
Return on sales
0%
Return on invested capital
-75.3%
Total debt ratio
12.94%
Debt ratio change over timeo
-1.25%
Current Ratio
16.76%
Quick Ratio
0%
Cash Position Ratio
14.58%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-13.4%
Return on assets
-9.74%
Return on sales
0%
Return on invested capital
-138.63%
Total debt ratio
21.61%
Debt ratio change over time
-1.31%
Current Ratio
13.67%
Quick Ratio
0%
Cash Position Ratio
6.08%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-81.62%
Return on assets
-83.99%
Return on sales
0%
Return on invested capital
-37.47%
Total debt ratio
-114.87%
Debt ratio change over time
-1.15%
Current Ratio
-13.53%
Quick Ratio
0%
Cash Position Ratio
-13.65%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | AGRX | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | -16.94% | 17.45% | 19.89% | 4.69% |
| Return on assets | -12.7% | 3.37% | 11.41% | 3.35% |
| Return on sales | 0% | 23.96% | 42.05% | 25.96% |
| Return on invested capital | -94.79% | 5.2% | -272.99% | 4.37% |
| Profitability | 0% | 69% | 75% | 50% |
| Total debt ratio | 22.19% | 77% | 53.92% | 57.66% |
| Debt ratio change over time | -1.15% | 0.36% | -1.16% | 10.77% |
| Dept financing | 7% | 26% | 18% | 44% |
| Current Ratio | 16.76% | 1.16% | 1.05% | 1.27% |
| Quick Ratio | 0% | 0.89% | 0.77% | 1.01% |
| Cash Position Ratio | 14.58% | 0.17% | 0.31% | 0.53% |
| Liquididy | 50% | 25% | 21% | 33% |
| Short-term ratios | AGRX | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | -12.29% | 44.06% | 17.3% | 6.24% |
| Return on assets | -10.59% | 3.88% | 9.33% | 3.22% |
| Return on sales | 0% | 27.04% | 40.02% | 24.93% |
| Return on invested capital | -75.3% | 9.69% | -224.06% | 4.96% |
| Profitability | 0% | 77% | 60% | 41% |
| Total debt ratio | 12.94% | 91.8% | 55.88% | 61.39% |
| Debt ratio change over time | -1.25% | 8.35% | -0.88% | 10.36% |
| Dept financing | 4% | 45% | 15% | 42% |
| Current Ratio | 16.76% | 1.16% | 1.05% | 1.27% |
| Quick Ratio | 0% | 0.89% | 0.77% | 1.01% |
| Cash Position Ratio | 14.58% | 0.17% | 0.31% | 0.53% |
| Liquididy | 50% | 24% | 21% | 28% |